MyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genes

Nucleic Acids Research

Volumn 35, Issue 21, 2007, Pages 7087-7095

  Shklover, Jeny ^a   Etzioni, Shulamit ^a   Weisman Shomer, Pnina ^a   Yafe, Anat ^a   Bengal, Eyal ^a   Fry, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA7 INTEGRIN; MITOCHONDRIAL CREATINE KINASE; MYOD PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; E BOX ELEMENT; GENE CLUSTER; GENE DELETION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

AMINO ACIDS, BASIC; ANIMALS; ANTIGENS, CD; BINDING SITES; CREATINE KINASE, MITOCHONDRIAL FORM; E-BOX ELEMENTS; G-QUADRUPLEXES; INTEGRIN ALPHA CHAINS; MICE; MUTATION; MYOD PROTEIN; PROMOTER REGIONS (GENETICS);

EID: 37549051304     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm746     Document Type: Article

References (35)

1. Holstege,F.C., Tantin,D., Carey,M., van der Vliet,P.C. and Timmers,H.T. (1995) The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA. EMBO J., 14, 810-819.
2. Liang,C.P. and Garrard,W.T. (1997) Template topology and transcription: chromatin templates relaxed by localized linearization are transcriptionally active in yeast. Mol. Cell. Biol., 17, 2825-2834.
3. Dexheimer,T.S., Fry,M. and Hurley,L.H. (2006) In Neidle,S. and Balasubramanian,S. (eds), Quadruplex Nucleic Acids, RSC Publishing, London, pp. 180-207.
4. Yafe,A., Etzioni,S., Weissman-Shomer,P. and Fry,M. (2005) Formation and properties of hairpin and tetraplex structures of guanine-rich regulatory sequences of muscle-specific genes. Nucleic Acids Res., 33, 2887-2900.
5. Etzioni,S., Yafe,A., Khateb,S., Weisman-Shomer,P., Bengal,E. and Fry,M. (2005) Homodimeric MyoD preferentially binds tetraplex structures of regulatory sequences of muscle-specific genes. J. Biol. Chem., 280, 26805-26812.
6. Tajbakhsh,S. (2003) Stem cells to tissue: Molecular, cellular and anatomical heterogeneity in skeletal muscle. Curr. Opin. Genet. Dev. 13, 413-422.
7. Schnorrer,F. and Dickson,B.J. (2004) Muscle building; mechanisms of myotube guidance and attachment site selection. Dev. Cell, 7 9-20.
8. Shi,X. and Garry,D.J. (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev., 20, 1692-1708.
9. Sabourin,L.A. and Rudnicki,M.A. (2000) The molecular regulation of myogenesis. Clin. Genet., 57, 16-25.
10. Berkes,C.A. and Tapscott,S.J. (2005) MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol., 16, 585-595.
11. Braun,T., Rudnicki,M.A., Arnold,H.H. and Jaenisch,R. (1992) Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell, 71, 369-382.
12. Rudnicki,M.A., Braun,T., Hinuma,S. and Jaenisch,R. (1992) Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell, 71 383-390.
13. Rudnicki,M.A., Schnegelsberg,P.N., Stead,R.H., Braun,T., Arnold,H.H. and Jaenisch,R. (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell, 75, 1351-1359.
14. Nabeshima,Y., Hanaoka,K., Hayasaka,M., Esumi,E., Li,S. and Nonaka,I. (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature, 364, 532-535.
15. Hasty,P., Bradley,A., Morris,J.H., Edmondson,D.G., Venuti,J.M., Olson,E.N. and Klein,W.H. (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature, 364 501-506.
16. Rawls,A., Morris,J.H., Rudnicki,M., Braun,T., Arnold,H.H., Klein,W.H. and Olson,E.N. (1995) Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. Dev. Biol., 172, 37-50.
17. Zhang,W., Behringer,R.R. and Olson,E.N. (1995) Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev., 9, 1388-1399.
18. Kassar-Duchossoy,L., Gayraud-Morel,B., Gomes,D., Rocancourt,D., Buckingham,M., Shinin,V. and Tajbakhsh,S. (2004) Mrf4 determines skeletal muscle identity in Myf5:MYod double-mutant mice. Nature, 431, 466-471.
19. Davis,R.L., Cheng,P.F., Lassar,A.B. and Weintraub,H. (1990) The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell, 60, 733-746.
20. Murre,C., McCaw,P.S., Vaessin,H., Caudy,M., Jan,L.Y., Jan,Y.N., Cabrera,C.V., Buskin,J.N., Hauschka,S.D. et al. (1989) Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell, 58, 537-544.
21. Rudnicki,M.A. and Jaenisch,R. (1995) The MyoD family of transcription factors and skeletal myogenesis. Bioessays, 17, 203-209.
22. Tapscott,S.J., Davis,R.L., Thayer,M.J., Cheng,P.F., Weintraub,H. ard Lassar,A.B. (1988) MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science, 242, 405-411.
23. Lassar,A.B., Davis,R.L., Wright,W.E., Kadesch,T., Murre,C., Voronova,A., Baltimore,D. and Weintraub,H. (1991) Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell, 66, 305-315.
24. Walsh,K. and Gualberto,A. (1992) MyoD binds to the guanine tetrad nucleic acid structure. J. Biol. Chem., 267, 13714-13718.
25. n. J. Biol. Chem., 274, 12797-12802.
26. n are destabilized by two heterogeneous nuclear ribonucleoprotein-related telomeric DNA-binding proteins. J. Biol. Chem., 275, 2231-2238.
27. Ralser,M., Querfurth,R., Warnatz,H.J., Lehrach,H., Yaspo,M.L. and Krobitsch,S. (2006) An efficient and economic enhancer mix for PCR. Biochem. Biophys. Res. Commun., 347, 747-751.
28. Sarig,G., Weisman-Shomer,P., Erlitzki,R. and Fry,M. (1997) Purification and characterization of qTBP42, a new single-stranded and quadruplex telomeric DNA-binding protein from rat hepatocytes. J. Biol. Chem. 272, 4474-4482.
29. Landau,M., Mayrose,I., Rosenberg,Y., Glaser,F., Martz,E., Pupko,T. and Ben-Tal,N. (2005) ConSurf 2005: The projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res., 33, W299-W302.
30. Ma,P.C., Rould,M.A., Weintraub,H. and Pabo,C.O. (1994) Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on DNA recognition and implications for transcriptional activation. Cell, 77, 451-459.
31. Brennan,T.J., Chakraborty,T. and Olson,E.N. (1991) Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl Acad. Sci. USA, 88, 5675-5679.
32. Davis,R.L. and Weintraub,H. (1992) Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science, 256, 1027-1030.
33. Weintraub,H., Genetta,T. and Kadesch,T. (1994) Tissue-specific gene activation by MyoD: Determination of specificity by cis-acting repression elements. Genes Dev., 8, 2203-2211.
34. Weintraub,H., Dwarki,V.J., Verma,I., Davis,R., Hollenberg,S., Snider,L., Lassar,A. and Tapscott,S.J. (1991) Muscle-specific transcriptional activation by MyoD. Genes Dev., 5, 1377-1386.
35. Huang,J., Weintraub,H. and Kedes,L. (1998) Intramolecular regulation of MyoD activation domain conformation and function. Mol. Cell. Biol. 18, 5478-5484.